Asahi Kasei has initiated a decisive restructuring of its petrochemical footprint at the Mizushima Works, specifically targeting the production of Acrylonitrile (AN) - a critical precursor for acrylic fibers and synthetic resins. By fiscal 2030, the company will decommission its 200 kt/y AN line and transition its methacrylonitrile facility to a co-production model. This move reflects a broader industrial shift toward capital efficiency, as the Material segment seeks to mitigate the volatility of primary chemical margins. While the restructuring involves businesses generating ¥116.2 billion in revenue, the corporation is maintaining its dominance in the textile value chain by leveraging its South Korean subsidiary, Tongsuh Petrochemical, to ensure uninterrupted supply to global apparel manufacturers.
Strengthening high-performance textile portfolios
The realignment extends to specialty chemical derivatives, including the discontinuation of the Mizushima polycarbonate diol (PCD) line. As fashion brands increasingly demand durable, sustainable alternatives to traditional materials, Asahi Kasei is centralizing its PCD operations—essential for high-grade synthetic leather - within its Chinese facilities. This logistical optimization allows the firm to capitalize on the $30 billion global technical textiles market, where demand for performance-driven polyurethane coatings is surging. Industry analysts suggest, by exiting low-margin domestic production, Asahi Kasei can better funnel resources into its ‘Trailblaze Together’ growth pillars, ensuring its legacy in cellulose fibers and advanced polymers evolves alongside the digital and green transitions currently redefining the global apparel landscape.
Material and healthcare synergy
Asahi Kasei is a multi-sector industrial leader focused on high-performance materials and healthcare solutions. Originally established as a cellulose fiber pioneer in 1922, the company now commands significant market share in synthetic resins and fibers across Asia and Europe. Current growth strategies prioritize the integration of sustainable chemistry and advanced electronics. Financially, the firm is focused on converting capital investments into higher margins, targeting a more robust return on equity through disciplined portfolio management and international expansion.












